- astrazeneca q4 core eps $1.67 approx $1.56 - q4 gross revenue increased 62% to $12,011m - saw '22 gross revenue increased by young high% - saw '22 core eps increased from mid to high twenty% - to increase the annual dividend from $0.10 to $2.90